During one year of pemafibrate therapy, serum levels of TG, AST, ALT, GGT and Mac-2 binding protein glycosylation isomer, which is the marker for liver fibrosis, were significantly improved (p < 0.05). This evidence concerns the gene GPT and Hepatic fibrosis.